Eli Lilly and Company (LLY)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 745.69 |
| Open | 752.64 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 1100 |
| Day's range | 728.78 - 752.64 |
| 52-week range | 380.77 - 800.78 |
| Volume | |
| Avg. volume | 3,063,427 |
| Market cap | 696.151B |
| Beta (5Y monthly) | 0.37 |
| PE ratio (TTM) | 126.68 |
| EPS (TTM) | 5.78 |
| Earnings date | 30 Apr 2024 |
| Forward dividend & yield | 5.20 (0.71%) |
| Ex-dividend date | 14 Feb 2024 |
| 1y target est | 826.94 |
ZacksWill Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.
Zacks4 Large Drug Stocks to Hold on to Amid Industry Challenges
Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and AbbVie (ABBV) are worth retaining in one's portfolio.
ZacksAnalysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.